Page last updated: 2024-10-15

3'-o-methylguanosine

Description

3'-O-methylguanosine : Guanosine with the hydrogen on the hydroxyl at position C-3' substituted with a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135742509
CHEBI ID70867
SCHEMBL ID1639395
MeSH IDM0113699

Synonyms (26)

Synonym
10300-27-3
2-amino-9-[(2r,3r,4s,5r)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-3h-purin-6-one
3'-o-methylguanosine
nsc 106541
guanosine, 3'-o-methyl-
3-omg
2-amino-9-[(2r,3r,4s,5r)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl]-3,9-dihydro-6h-purin-6-one
CHEBI:70867
SCHEMBL1639395
2-amino-9-((2r,3r,4s,5r)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-1,9-dihydro-6h-purin-6-one
3'-o-methyl-guanosine
3'-o-methyl-d-guanosine
mfcd00057057
2-amino-9-[(2r,3r,4s,5r)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-6,9-dihydro-3h-purin-6-one
AKOS027339985
Q27139158
AS-47255
AKOS037644149
F12911
3 INVERTED EXCLAMATION MARKA-O-METHYLGUANOSINE
cid 97217
A855649
CS-0137787
HY-W091784
2-amino-9-[(2r,3r,4s,5r)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-6,9-dihydro-1h-purin-6-one
BP-58840
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methylguanosineAny guanosine carrying one or more methyl substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (12.50)18.7374
1990's2 (8.33)18.2507
2000's16 (66.67)29.6817
2010's3 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.17%)4.05%
Observational0 (0.00%)0.25%
Other21 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]